Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 379871011000036114 | paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 379872011000036115 | codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg + paracetamol 500 mg capsule (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | Is a | paracetamol 500 mg capsule | true | Inferred relationship | Some | ||
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | Is a | paracetamol + codeine + doxylamine | true | Inferred relationship | Some | ||
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | has intended active ingredient | doxylamine | true | Inferred relationship | Some | 1175565734 | |
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | has Australian BoSS | doxylamine succinate | true | Inferred relationship | Some | 1175565734 | |
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | has intended active ingredient | paracetamol | true | Inferred relationship | Some | 1014704092 | |
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | has Australian BoSS | paracetamol | true | Inferred relationship | Some | 1014704092 | |
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | has intended active ingredient | codeine | true | Inferred relationship | Some | 958838619 | |
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | has Australian BoSS | codeine phosphate hemihydrate | true | Inferred relationship | Some | 958838619 | |
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 1175565735 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fiorinal Dental capsule | Is a | True | paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | Inferred relationship | Some | |
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule, 2 | has MPUU | True | paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | Inferred relationship | Some | 1 |
| paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule, 20 | has MPUU | True | paracetamol 500 mg + codeine phosphate hemihydrate 10 mg + doxylamine succinate 2 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Tasmania reportable Schedule 4 medications reference set
Victoria reportable Schedule 4 medications reference set
South Australia reportable Schedule 4 medications reference set
Queensland Health QScript Schedule 4 monitored medicines reference set
New South Wales Reportable Schedule 4 medications reference set
Northern Territory Reportable Schedule 4 medications reference set
ACT Reportable Schedule 4 medications reference set
Western Australia Health Schedule 4 restricted medicines for public hospitals reference set
Medicinal product unit of use reference set
FHIR